116 related articles for article (PubMed ID: 8399074)
1. Depletion of lipoprotein lipase after heparin administration.
Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
Arterioscler Thromb; 1993 Oct; 13(10):1391-6. PubMed ID: 8399074
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
Persson E
Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
[TBL] [Abstract][Full Text] [Related]
3. Interaction of size-fractionated heparins with lipoprotein lipase and hepatic lipase in the rat.
Liu G; Hultin M; Ostergaard P; Olivecrona T
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):731-6. PubMed ID: 1497611
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro release of lipoprotein lipase and hepatic lipase by low molecular weight heparins.
Meraihi Z; Lutz O; Frey A; Bach AC
Arch Int Pharmacodyn Ther; 1989; 297():286-93. PubMed ID: 2543347
[TBL] [Abstract][Full Text] [Related]
5. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.
Näsström B; Stegmayr B; Gupta J; Olivecrona G; Olivecrona T
Nephrol Dial Transplant; 2005 Jun; 20(6):1172-9. PubMed ID: 15797889
[TBL] [Abstract][Full Text] [Related]
6. Release of lipoprotein lipase and hepatic lipase activities. Effects of heparin and a low molecular weight heparin fragment.
Persson E; Nilsson-Ehle P
Scand J Clin Lab Invest; 1990 Feb; 50(1):43-9. PubMed ID: 2156335
[TBL] [Abstract][Full Text] [Related]
7. Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.
Brodin E; Svensson B; Paulssen RH; Nordoy A; Hansen JB
J Lab Clin Med; 2004 Nov; 144(5):246-53; discussion 226-7. PubMed ID: 15570242
[TBL] [Abstract][Full Text] [Related]
8. Plasma kinetics of lipoprotein lipase and hepatic lipase activities induced by heparin and a low molecular weight heparin fragment.
Persson E; Nordenström J; Nilsson-Ehle P
Scand J Clin Lab Invest; 1987 Apr; 47(2):151-5. PubMed ID: 3576117
[TBL] [Abstract][Full Text] [Related]
9. New aspects on heparin and lipoprotein metabolism.
Olivecrona T; Bengtsson-Olivecrona G; Ostergaard P; Liu G; Chevreuil O; Hultin M
Haemostasis; 1993 Mar; 23 Suppl 1():150-60. PubMed ID: 8388350
[TBL] [Abstract][Full Text] [Related]
10. Heparin-decasaccharides impair the catabolism of chylomicrons.
Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):437-44. PubMed ID: 8973550
[TBL] [Abstract][Full Text] [Related]
11. Effects of heparin and low molecular weight heparin on lipid transport during parenteral feeding in the rat.
Roth B; Ekelund M; Fan BG; Ekstrom U; Nilsson-Ehle P
Acta Anaesthesiol Scand; 1996 Jan; 40(1):102-11. PubMed ID: 8904267
[TBL] [Abstract][Full Text] [Related]
12. Effects of heparin on the uptake of lipoprotein lipase in rat liver.
Neuger L; Vilaró S; Lopez-Iglesias C; Gupta J; Olivecrona T; Olivecrona G
BMC Physiol; 2004 Nov; 4(1):13. PubMed ID: 15544705
[TBL] [Abstract][Full Text] [Related]
13. Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin.
Braun JE; Severson DL
Lipids; 1993 Jan; 28(1):59-61. PubMed ID: 8383273
[TBL] [Abstract][Full Text] [Related]
14. Intestinal absorption of low molecular weight heparin in animals and human subjects.
Nissan A; Ziv E; Kidron M; Bar-On H; Friedman G; Hyam E; Eldor A
Haemostasis; 2000; 30(5):225-32. PubMed ID: 11251329
[TBL] [Abstract][Full Text] [Related]
15. Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme.
Nasstrom B; Stegmayr BG; Olivecrona G; Olivecrona T
J Lab Clin Med; 2003 Aug; 142(2):90-9. PubMed ID: 12960955
[TBL] [Abstract][Full Text] [Related]
16. Low-Mr heparin is as potent as conventional heparin in releasing lipoprotein lipase, but is less effective in preventing hepatic clearance of the enzyme.
Liu GQ; Bengtsson-Olivecrona G; Ostergaard P; Olivecrona T
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):747-52. PubMed ID: 1996970
[TBL] [Abstract][Full Text] [Related]
17. Release of lipoprotein lipase to plasma by triacylglycerol emulsions. Comparison to the effect of heparin.
Hultin M; Bengtsson-Olivecrona G; Olivecrona T
Biochim Biophys Acta; 1992 Apr; 1125(1):97-103. PubMed ID: 1567914
[TBL] [Abstract][Full Text] [Related]
18. The effects of post-heparin plasma lipases on anti-Xa clotting activity.
Williams SP; Barrowcliffe TW
Thromb Res; 1985 Feb; 37(3):371-7. PubMed ID: 3992526
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein lipase in hemodialysis patients: indications that low molecular weight heparin depletes functional stores, despite low plasma levels of the enzyme.
Näsström B; Stegmayr B; Olivecrona G; Olivecrona T
BMC Nephrol; 2004 Nov; 5():17. PubMed ID: 15527497
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted.
Näsström B; Olivecrona G; Olivecrona T; Stegmayr BG
J Lab Clin Med; 2001 Sep; 138(3):206-13. PubMed ID: 11528374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
